The reaction of an aminopolycarboxylate ligand, aspartic-N-monoacetic acid (ASMA), with [Re(CO)3(H2O)3]+ was examined. The tridentate coordination of ASMA to this ReI tricarbonyl precursor yielded fac-Re(CO)3(ASMA) as a mixture of diastereomers. The chemistry is analogous to that of the TcI tricarbonyl complex, which yields fac-99mTc(CO)3(ASMA) under similar conditions. The formation, structure, and isomerization of fac-Re(CO)3(ASMA) products were characterized by HPLC, 1H NMR spectroscopy, and X-ray crystallography. The two major fac-Re(CO)3(ASMA) diastereomeric products each have a linear ONO coordination mode with two adjacent five-membered chelate rings, but they differ in the endo or exo orientation of the uncoordinated acetate group, in agreement with expectations based on previous studies. Conditions have been identified for the expedient isomerization of fac-Re(CO)3(ASMA) to a mixture consisting primarily of one major product. Because different isomeric species typically have different pharmacokinetic characteristics, these conditions may provide for the practical isolation of a single 99mTc(CO)3(ASMA) species, thus allowing the isolation of the isomer that has optimal imaging and pharmacokinetic characteristics. This information will aid in the design of future 99mTc radiopharmaceuticals.
The reaction of an aminopolycarboxylaten class="Chemical">ligand, aspartic-N-monoacetic acid (ASMA), with [Re(CO)3(H2O)3]+ was examined. The tridentate coordination of ASMA to this ReI tricarbonyl precursor yielded fac-Re(CO)3(ASMA) as a mixture of diastereomers. The chemistry is analogous to that of the TcI tricarbonyl complex, which yields fac-99mTc(CO)3(ASMA) under similar conditions. The formation, structure, and isomerization of fac-Re(CO)3(ASMA) products were characterized by HPLC, 1HNMR spectroscopy, and X-ray crystallography. The two major fac-Re(CO)3(ASMA) diastereomeric products each have a linear ONO coordination mode with two adjacent five-membered chelate rings, but they differ in the endo or exo orientation of the uncoordinated acetate group, in agreement with expectations based on previous studies. Conditions have been identified for the expedient isomerization of fac-Re(CO)3(ASMA) to a mixture consisting primarily of one major product. Because different isomeric species typically have different pharmacokinetic characteristics, these conditions may provide for the practical isolation of a single 99mTc(CO)3(ASMA) species, thus allowing the isolation of the isomer that has optimal imaging and pharmacokinetic characteristics. This information will aid in the design of future 99mTc radiopharmaceuticals.
Authors: Elisa García Garayoa; Dominique Rüegg; Peter Bläuenstein; Martin Zwimpfer; Irfan Ullah Khan; Veronique Maes; Alain Blanc; Annette G Beck-Sickinger; Dirk A Tourwé; P August Schubiger Journal: Nucl Med Biol Date: 2006-11-28 Impact factor: 2.408
Authors: Simon P Fricker; Renee M Mosi; Beth R Cameron; Ian Baird; Youngbao Zhu; Virginia Anastassov; Jennifer Cox; Patricia S Doyle; Elizabeth Hansell; Gloria Lau; Jonathan Langille; Micki Olsen; Ling Qin; Renato Skerlj; Rebecca S Y Wong; Zefferino Santucci; James H McKerrow Journal: J Inorg Biochem Date: 2008-06-04 Impact factor: 4.155
Authors: Haiyang He; Malgorzata Lipowska; Anna Maria Christoforou; Luigi G Marzilli; Andrew T Taylor Journal: Nucl Med Biol Date: 2007-08 Impact factor: 2.408
Authors: Malgorzata Lipowska; Nashwa Jarkas; Ronald J Voll; Jonathon A Nye; Jeffrey Klenc; Mark M Goodman; Andrew T Taylor Journal: Nucl Med Biol Date: 2017-12-27 Impact factor: 2.408
Authors: Malgorzata Lipowska; Jeffrey Klenc; Nashwa Jarkas; Luigi G Marzilli; Andrew T Taylor Journal: Nucl Med Biol Date: 2016-12-27 Impact factor: 2.408